Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies.
about
Efficacy and Safety of Teneligliptin 40 mg in Type 2 Diabetes: A Pooled Analysis of Two Phase III Clinical Studies.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Efficacy and Safety of Tenelig ...... wo Phase III Clinical Studies.
@en
Efficacy and Safety of Tenelig ...... wo Phase III Clinical Studies.
@nl
type
label
Efficacy and Safety of Tenelig ...... wo Phase III Clinical Studies.
@en
Efficacy and Safety of Tenelig ...... wo Phase III Clinical Studies.
@nl
prefLabel
Efficacy and Safety of Tenelig ...... wo Phase III Clinical Studies.
@en
Efficacy and Safety of Tenelig ...... wo Phase III Clinical Studies.
@nl
P2093
P2860
P1433
P1476
Efficacy and Safety of Tenelig ...... wo Phase III Clinical Studies.
@en
P2093
Manabu Ishii
Miyuki Matsukawa
Takashi Kadowaki
Yoshiteru Ushirogawa
P2860
P2888
P304
P356
10.1007/S13300-018-0372-X
P577
2018-02-12T00:00:00Z